Stable Isotopes Product Detail
Home Stable Isotopes CS-T-96390

N(1-(3-Methylbutanamido) N(1-Des(boric Acid))-d9 Bortezomib

Explore technical data, documentation access, molecular information and enquiry options for this Clearsynth research product.

Product Code: CS-T-96390 Stable Isotopes Research Use Only
N(1-(3-Methylbutanamido) N(1-Des(boric Acid))-d9 Bortezomib
Category
Stable Isotopes
API Family
--
Product Code
CS-T-96390
Research Status
For Laboratory Use

N(1-(3-Methylbutanamido) N(1-Des(boric Acid))-d9 Bortezomib

Stable Isotopes
Stock Status: : Enquire Live

CAT No.
CS-T-96390
CAS No.
2714485-78-4
Molecular Formula
C19H13D9N4O3
Molecular Weight
363.49
Login to view price
There is no hazardous surcharge associated with this product.
There is no packaging charge associated with this product.
For Research Purposes only. Not for Personal or Veterinary use.
All compounds supplied are strictly intended for laboratory, research, analytical, and scientific use only. They are not meant for human consumption, therapeutic use, or any form of clinical application.
CAS No.
2714485-78-4
Product Code
CS-T-96390
M.F.
C19H13D9N4O3
M.W.
363.49
Smiles
O=C(C1=NC=CN=C1)N[C@H](C(NC(C([2H])([2H])C([2H])(C([2H])([2H])[2H])C([2H])([2H])[2H])=O)=O)CC2=CC=CC=C2
Category
Stable Isotopes
Storage Condition
Refer MSDS for complete information.
IUPAC Name
N(1-(3-Methylbutanamido) N(1-Des(boric Acid))-d9 Bortezomib
References
"Nawrocki, S.T., et al: Cancer Research, 65, 11510 (2005); Drahl C.: Chem. and Eng. News, 87, 41 (2009);"
Synonyms
(S)-N-(1-(3-Methylbutanamido)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxamide-d9;
Application Notes
"Isotope labelled N(1-(3-Methylbutanamido) N(1-Des(boric Acid)) Bortezomib is an impurity of Bortezomib (B675700), the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer."
Hazard Compound
Refer MSDS for complete information.
Overview
"Isotope labelled N(1-(3-Methylbutanamido) N(1-Des(boric Acid)) Bortezomib is an impurity of Bortezomib (B675700), the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer."

Refund Policy

We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of material handover. We have invested in the highest quality packaging materials and use international logistics partners to service our customers. If there is an issue with one or more of our products, it must be reported to us within 45 days of your receiving shipment for refund or account credit eligibility.

Downloading MSDS…
Quick Enquiry Email Us
Quick Enquiry
Tell us what you need
Quote Basket
Selected RFQ Items
Your RFQ basket is empty. Add a product block or copy a guided requirement here.